Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

Cited In for PubMed (Select 17959805)


Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes.

Wang H, Pati S, Pozzo-Miller L, Doering LC.

Front Cell Neurosci. 2015 Feb 26;9:55. doi: 10.3389/fncel.2015.00055. eCollection 2015. Review.


Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.

Myrick LK, Deng PY, Hashimoto H, Oh YM, Cho Y, Poidevin MJ, Suhl JA, Visootsak J, Cavalli V, Jin P, Cheng X, Warren ST, Klyachko VA.

Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):949-56. doi: 10.1073/pnas.1423094112. Epub 2015 Jan 5.


Meet the players: local translation at the synapse.

Fernandez-Moya SM, Bauer KE, Kiebler MA.

Front Mol Neurosci. 2014 Nov 11;7:84. doi: 10.3389/fnmol.2014.00084. eCollection 2014.


Human FMRP contains an integral tandem Agenet (Tudor) and KH motif in the amino terminal domain.

Myrick LK, Hashimoto H, Cheng X, Warren ST.

Hum Mol Genet. 2015 Mar 15;24(6):1733-40. doi: 10.1093/hmg/ddu586. Epub 2014 Nov 20.


Early life seizures: evidence for chronic deficits linked to autism and intellectual disability across species and models.

Bernard PB, Benke TA.

Exp Neurol. 2015 Jan;263:72-8. doi: 10.1016/j.expneurol.2014.09.018. Epub 2014 Oct 2.


Muscarinic cholinergic receptors modulate inhibitory synaptic rhythms in hippocampus and neocortex.

Alger BE, Nagode DA, Tang AH.

Front Synaptic Neurosci. 2014 Sep 5;6:18. doi: 10.3389/fnsyn.2014.00018. eCollection 2014. Review.


An acetylcholinesterase inhibitor, eserine, induces long-term depression at CA3-CA1 synapses in the hippocampus of adult rats.

Mans RA, Warmus BA, Smith CC, McMahon LL.

J Neurophysiol. 2014 Nov 15;112(10):2388-97. doi: 10.1152/jn.00048.2014. Epub 2014 Aug 20.


mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo.

Hu NW, Nicoll AJ, Zhang D, Mably AJ, O'Malley T, Purro SA, Terry C, Collinge J, Walsh DM, Rowan MJ.

Nat Commun. 2014 Mar 4;5:3374. doi: 10.1038/ncomms4374.


The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.

Uzunova G, Hollander E, Shepherd J.

Curr Neuropharmacol. 2014 Jan;12(1):71-98. doi: 10.2174/1570159X113116660046.


From FMRP function to potential therapies for fragile X syndrome.

Sethna F, Moon C, Wang H.

Neurochem Res. 2014 Jun;39(6):1016-31. doi: 10.1007/s11064-013-1229-3. Epub 2013 Dec 18. Review.


Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome.

Fish EW, Krouse MC, Stringfield SJ, Diberto JF, Robinson JE, Malanga CJ.

PLoS One. 2013 Oct 18;8(10):e77896. doi: 10.1371/journal.pone.0077896. eCollection 2013.


Degradation of high affinity HuD targets releases Kv1.1 mRNA from miR-129 repression by mTORC1.

Sosanya NM, Huang PP, Cacheaux LP, Chen CJ, Nguyen K, Perrone-Bizzozero NI, Raab-Graham KF.

J Cell Biol. 2013 Jul 8;202(1):53-69. doi: 10.1083/jcb.201212089.


Phosphorylation of FMRP and alterations of FMRP complex underlie enhanced mLTD in adult rats triggered by early life seizures.

Bernard PB, Castano AM, O'Leary H, Simpson K, Browning MD, Benke TA.

Neurobiol Dis. 2013 Nov;59:1-17. doi: 10.1016/j.nbd.2013.06.013. Epub 2013 Jul 2.


Fragile X mental retardation protein and synaptic plasticity.

Sidorov MS, Auerbach BD, Bear MF.

Mol Brain. 2013 Apr 8;6:15. doi: 10.1186/1756-6606-6-15. Review.


Inhibition of spontaneous recovery of fear by mGluR5 after prolonged extinction training.

Mao SC, Chang CH, Wu CC, Orejarena MJ, Manzoni OJ, Gean PW.

PLoS One. 2013;8(3):e59580. doi: 10.1371/journal.pone.0059580. Epub 2013 Mar 21. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/a71a5aba-ee14-439b-8952-69641642b71f. Orejanera, Maria Juliana [corrected to Orejarena, M Juliana].


Postsynaptic FMRP bidirectionally regulates excitatory synapses as a function of developmental age and MEF2 activity.

Zang T, Maksimova MA, Cowan CW, Bassel-Duby R, Olson EN, Huber KM.

Mol Cell Neurosci. 2013 Sep;56:39-49. doi: 10.1016/j.mcn.2013.03.002. Epub 2013 Mar 17.


Hippocampal Gαq/₁₁ but not Gαo-coupled receptors are altered in aging.

McQuail JA, Davis KN, Miller F, Hampson RE, Deadwyler SA, Howlett AC, Nicolle MM.

Neuropharmacology. 2013 Jul;70:63-73. doi: 10.1016/j.neuropharm.2013.01.009. Epub 2013 Jan 21.


Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice.

Bhattacharya A, Kaphzan H, Alvarez-Dieppa AC, Murphy JP, Pierre P, Klann E.

Neuron. 2012 Oct 18;76(2):325-37. doi: 10.1016/j.neuron.2012.07.022. Epub 2012 Oct 17.


Longitudinal in vivo developmental changes of metabolites in the hippocampus of Fmr1 knockout mice.

Shi D, Xu S, Waddell J, Scafidi S, Roys S, Gullapalli RP, McKenna MC.

J Neurochem. 2012 Dec;123(6):971-81. doi: 10.1111/jnc.12048. Epub 2012 Nov 7.


Muscarinic control of AMPA receptor responsiveness in mouse spinal cord motoneurons.

Mejia-Gervacio S.

J Physiol. 2012 Oct 1;590(Pt 19):4663-71. doi: 10.1113/jphysiol.2012.238444. Epub 2012 Aug 13.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk